Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01398150 · ClinicalTrials.gov registry record · NA

Cranberry Enhances Human Immune Function and Reduces Illness

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
54
Enrollment target

NCT01398150 is a NA study that has completed, run by University of Florida. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01398150, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
54 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether consuming a beverage made with cranberry polyphenols and proanthocyanidins is effective in modifying immune function by enhancing immune cell proliferation, cytokine production, and antioxidant capacity. If immune cell proliferation is improved, the subjects are expected to have fewer cold and flu symptoms.

Interventions

  • DIETARY_SUPPLEMENT Beverage made to look like the cranberry beverage
  • DIETARY_SUPPLEMENT Beverage made from cranberry compounds

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2009-03
Est. Completion 2009-05
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01398150

The ClinicalTrials.gov registry entry for NCT01398150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Beverage made to look like the cranberry beverage is the first listed.

NCT01398150 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01398150 about?

NCT01398150 is a clinical study titled "Cranberry Enhances Human Immune Function and Reduces Illness". The purpose of this study is to determine whether consuming a beverage made with cranberry polyphenols and proanthocyanidins is effective in modifying immune function by enhancing immune cell proliferation, cytokine production, and antioxidant capacity. If immune cell proliferation is improved, the ...

What is the current status of trial NCT01398150?

This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2009-03. Estimated completion is 2009-05.

What interventions are being tested in trial NCT01398150?

The interventions under investigation include: Beverage made to look like the cranberry beverage (DIETARY_SUPPLEMENT), Beverage made from cranberry compounds (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01398150?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.